Summary
Oxygen radicals particularly superoxide and hydroxyl radicals are very reactive species believed to be involved in cell and tissue damage in a variety of diseases including inflammatory bowel disease (IBD). Today there are four major arguments for such a role in IBD: Infiltration of the inflamed intestinal mucosa with myeloperoxidase containing activated neutrophils able to produce superoxide, hydroxyl and hypochlorite, increased chemoluminescence response of peripheral and mucosal phagocytic cells to various stimuli, decreased inflammation following specific scavenger treatment in animal models of colitis and defined radical scavenger and inhibitory properties of drugs, especially aminosalicylates used in the therapy of IBD. In the absence of a specific therapy, radical scavenging and/or inhibition may be an adjunctive modality in IBD.
Similar content being viewed by others
Abbreviations
- IBO:
-
inflammatory bowel disease
- MPO:
-
myeloperoxidase
- FMLP:
-
formyl-methionyl-leucyl-peptide
- 5-ASA:
-
5-aminosalicylic acid
- ESR:
-
electron spin resonance
References
Allgayer H, De Schryver K, Stenson WF (1989) Treatment with 16, 16′ dimethylprostaglandin E2 before and after induction of colitis with trinitrobenzene sulfonic acid in rats decreases inflammation. Gastroenterology 96:1290–1300
Allgayer H, Kruis W (1990) Recent developments in the pathology of inflammatory bowel disease: future therapeutic approaches. Z Gastroenterol 28:117–120
Allgayer H, Höfer P, Schmidt M, Böhne P, Kruis W, Gugler R (1990) Different radical scavenger properties of 5-aminosalicylic acid (5-ASA) and its derivatives: a comparative electron spin resonance (ESR) study. Gastroenterology 98 (5):A156 (abstract)
Allgayer H, Rang S, Höfer P, Kruis W, Retey J, Gugler R (1991) Superoxide radical (O .2 ) inhibition by sulfasalazine (SAZ) and aminosalicylates: extra vs. intracellular action. Gastroenterology 100(5):A556 (Abstract)
Arouma OI, Wasil M, Halliwell B, Hoey B, Butler J (1987) The scavenging of oxidants by sulfasalazine and its metabolites. Biochem Pharmacol 36:3739–3742
Cross CE, moderator (1987) Oxygen radicals and human disease. Ann Intern Med 107:526–545
Culcasi M, Pietri S, Cozzone PJ (1989) Use of 3, 3′, 5, 5′-tetramethyl-1-pyrroline-1-oxide spin trap for the continous flow ESR monitoring of hydroxyl radical generation in the ischemic and reperfused myocardium. Biochem Biophy Res Comm 164:1274–1280
Curran FT, Allan RN, Keighley MRB (1991) Superoxide production by Crohn's disease neutrophils. Gut 32:399–402
Ginzberg AL, Albert MB (1988) Pilot trial of enteric coated 4-ASA in severe steroid dependent inflammatory bowel disease. Gastroenterology 94:A147 (Abstract)
Graham Williams J (1990) Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment. Ann Roy Coll Surg Engl 72, 263–262
Grisham MB, Granger DN (1988) Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Dig Dis Sci 33 (Suppl):69–159
Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M (1990) Role of reactive oxygen metabolites in experimental colitis. Gut 31:786–790
Koningsberger JC, Marx JJM, van Hattum J (1988) Free radicals in gastroenterology — a review. Scand J Gastroenterol 23 (suppl) 154:30–40
Kvietys PR, Morgan Smith S, Grisham MB, Manci EA (1988) 5-Aminosalicylic acid protects against ischemia/reperfusion-induced gastric bleeding in the rat. Gastroenterology 94:733–788
Lobos EA, Sharon P, Stenson WT (1987) Chemotactic activity in inflammatory bowel disease: role of leukotriene B4. Dig Dis Sci 32:1380–1388
Miyachi J, Yoshioka A, Imamura S, Niwa J (1987) Effect of sulfasalazine and its metabolites on the generation of reactive oxygen species. Gut 28:190–195
Shiratara J et al. (1989) Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 44:163–171
Sharon P, Stenson WF (1985) Metabolism of arachidonic acid in acetic acid colitis in rats: Similarity to human inflammatory bowel disease. Gastroenterology 88:55–63
Stenson WF (1988) Leucotriene B4 in inflammatory bowel disease. In: Goebell H, Peskar PM, Malchow H (eds) Inflammatory bowel diseases. MTP Press, Lancaster Boston The Hague Dordrecht, pp 143–152
Simmonds NJ, Allan RE, Stevens TRJ, van Someren RNM, Blake DR, Rampton DS (1991) Colorectal mucosa in inflammatory bowel disease produces reactive oxygen metabolites, principally hypochlorite. Gut 32:A589 (Abstract)
Verspaget HW, Pena AS, Weterman IT, Lamers CBHW (1988) Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxiddismutase content. Gut 29:223–228
Author information
Authors and Affiliations
Additional information
Manuscripts published in this issue were the matter of a Symposium held at the University of Ulm, April 24–27, 1991
Rights and permissions
About this article
Cite this article
Allgayer, H. Clinical relevance of oxygen radicals in inflammatory bowel disease — Facts and fashion. Klin Wochenschr 69, 1001–1003 (1991). https://doi.org/10.1007/BF01645146
Issue Date:
DOI: https://doi.org/10.1007/BF01645146